Status:
COMPLETED
Nuclear Magnetic Resonance Spectroscopic Analysis of Urinary Metabolome in Sarcoidosis (RMN-SARCURINES)
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Sarcoidosis
Eligibility:
All Genders
18-80 years
Brief Summary
"Sarcoidosis is a systemic granulomatous disease of unknown cause(s).Determining disease activity is a major element in the treatment decision. 1H- Nuclear magnetic resonance (NMR) spectroscopy allow...
Detailed Description
"Sarcoidosis is a systemic granulomatous disease of unknown cause(s) with an almost constant lung involvement. Clinical expression varies greatly in both evolution and severity. The activity of the di...
Eligibility Criteria
Inclusion
- Patients with a diagnosis of sarcoidosis according to ATS / ERS / WASOG criteria.
Exclusion
- Treatment (corticosteroids, plaquenil, immunosuppressants) within the last 6 months
- Patients with diabetes.
- Patient with long-term or recent drug treatment (e.g. antibiotics)
- Patients with a urinary tract infection or urinary lithiasis at the time of collection.
- Renal failure
Key Trial Info
Start Date :
January 30 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT05181930
Start Date
January 30 2018
End Date
June 1 2021
Last Update
May 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Avicenne,AP-HP
Bobigny, France, 93009